These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 33737909)

  • 41. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.
    Farrar D; Tuffnell DJ; West J; West HM
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD005542. PubMed ID: 27272351
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quality of life in Danish children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion or multiple daily injections.
    Birkebaek NH; Kristensen LJ; Mose AH; Thastum M;
    Diabetes Res Clin Pract; 2014 Dec; 106(3):474-80. PubMed ID: 25451903
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment.
    Scott ES; McGrath RT; Januszewski AS; Calandro D; Hardikar AA; O'Neal DN; Fulcher G; Jenkins AJ
    BMJ Open; 2019 Dec; 9(12):e033059. PubMed ID: 31888933
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of insulin pump therapy on long-term glycemic control in a pediatric Spanish cohort.
    Colino E; Martín-Frías M; Yelmo R; Álvarez MÁ; Roldán B; Barrio R
    Diabetes Res Clin Pract; 2016 Mar; 113():69-76. PubMed ID: 26972965
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning.
    Cyganek K; Hebda-Szydlo A; Katra B; Skupien J; Klupa T; Janas I; Kaim I; Sieradzki J; Reron A; Malecki MT
    Diabetes Technol Ther; 2010 Jan; 12(1):41-7. PubMed ID: 20082584
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes.
    Herman WH; Ilag LL; Johnson SL; Martin CL; Sinding J; Al Harthi A; Plunkett CD; LaPorte FB; Burke R; Brown MB; Halter JB; Raskin P
    Diabetes Care; 2005 Jul; 28(7):1568-73. PubMed ID: 15983302
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial.
    Weintrob N; Benzaquen H; Galatzer A; Shalitin S; Lazar L; Fayman G; Lilos P; Dickerman Z; Phillip M
    Pediatrics; 2003 Sep; 112(3 Pt 1):559-64. PubMed ID: 12949284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.
    Hanaire-Broutin H; Melki V; Bessières-Lacombe S; Tauber JP
    Diabetes Care; 2000 Sep; 23(9):1232-5. PubMed ID: 10977011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes.
    Willi SM; Planton J; Egede L; Schwarz S
    J Pediatr; 2003 Dec; 143(6):796-801. PubMed ID: 14657831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and Safety of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Injections on Type 1 Diabetes Children: A Meta-Analysis of Randomized Control Trials.
    Qin Y; Yang LH; Huang XL; Chen XH; Yao H
    J Clin Res Pediatr Endocrinol; 2018 Nov; 10(4):316-323. PubMed ID: 30015622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Continuous Subcutaneous Infusion Versus Multiple Daily Injections of Insulin for Pregestational Diabetes in Pregnancy: A Systematic Review and Meta-Analysis.
    Fisher SA; Huang J; DuBord AY; Xu NY; Beestrum M; Niznik C; Yeung AM; Nguyen KT; Klonoff DC; Yee LM
    J Diabetes Sci Technol; 2023 Sep; 17(5):1337-1363. PubMed ID: 37542367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prospective assessment of continuous subcutaneous insulin infusion therapy in young children with type 1 diabetes.
    Minkina-Pedras M; Jarosz-Chobot P; Polanska J; Kalina MA; Marcinkowski A; Malecka-Tendera E
    Diabetes Res Clin Pract; 2009 Aug; 85(2):153-8. PubMed ID: 19539392
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.
    Doyle EA; Weinzimer SA; Steffen AT; Ahern JA; Vincent M; Tamborlane WV
    Diabetes Care; 2004 Jul; 27(7):1554-8. PubMed ID: 15220227
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
    Sulli N; Shashaj B
    Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial.
    Hoogma RP; Hammond PJ; Gomis R; Kerr D; Bruttomesso D; Bouter KP; Wiefels KJ; de la Calle H; Schweitzer DH; Pfohl M; Torlone E; Krinelke LG; Bolli GB;
    Diabet Med; 2006 Feb; 23(2):141-7. PubMed ID: 16433711
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proportion of Basal to Total Insulin Dose Is Associated with Metabolic Control, Body Mass Index, and Treatment Modality in Children with Type 1 Diabetes-A Cross-Sectional Study with Data from the International SWEET Registry.
    Rasmussen VF; Vestergaard ET; Schwandt A; Beltrand J; Rami-Merhar B; O'Riordan SMP; Jarosz-Chobot P; Castro-Correia C; Gevers EF; Birkebæk NH
    J Pediatr; 2019 Dec; 215():216-222.e1. PubMed ID: 31345576
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis.
    Monami M; Lamanna C; Marchionni N; Mannucci E
    Acta Diabetol; 2010 Dec; 47 Suppl 1():77-81. PubMed ID: 19504039
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review.
    Roze S; Smith-Palmer J; Valentine W; de Portu S; Nørgaard K; Pickup JC
    Diabet Med; 2015 Nov; 32(11):1415-24. PubMed ID: 25962621
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison between sensor-augmented insulin therapy with continuous subcutaneous insulin infusion or multiple daily injections in everyday life: 3-day analysis of glucose patterns and sensor accuracy in children.
    Zucchini S; Scipione M; Balsamo C; Maltoni G; Rollo A; Molinari E; Mangoni L; Cicognani A
    Diabetes Technol Ther; 2011 Dec; 13(12):1187-93. PubMed ID: 21854193
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.
    Colquitt JL; Green C; Sidhu MK; Hartwell D; Waugh N
    Health Technol Assess; 2004 Oct; 8(43):iii, 1-171. PubMed ID: 15488165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.